| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,842 |
22,700 |
$810K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,172 |
5,177 |
$344K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,218 |
8,543 |
$307K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,606 |
7,008 |
$192K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,822 |
2,484 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
678 |
592 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
299 |
278 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,586 |
931 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,886 |
3,055 |
$6K |
| 87400 |
|
1,634 |
962 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29 |
27 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
253 |
67 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
544 |
346 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
92 |
87 |
$993.48 |
| 81002 |
|
437 |
366 |
$727.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
524 |
418 |
$331.08 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
443 |
262 |
$52.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
475 |
311 |
$13.26 |